Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 14/20 | 0.54 |
| ▸ | SNCA | P37840 | 1/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17386357 | 0.87 | CYP3A4 (0.50) | CYP3A4NPSR1SMN1; SMN2PKMALDH1A1 | |
| SCHEMBL29620611 | 0.82 | CYP3A4 (0.46) | CYP3A4NPSR1SMN1; SMN2PKMALDH1A1 | |
| SCHEMBL203679 | 0.82 | ALDH1A1 (0.61) | CYP3A4NPSR1SMN1; SMN2PKMALDH1A1 | |
| SCHEMBL9280186 | 0.81 | NAPRT (0.54) | CYP19A1CYP3A4NPSR1 | |
| Hydrochloric Acid SCHEMBL25259767 | 0.81 | ALDH1A1 (0.59) | CYP3A4NPSR1SMN1; SMN2PKMALDH1A1 | |
| SCHEMBL5687587 | 0.81 | CA2 (0.47) | CYP3A4NPSR1SMN1; SMN2PKMALDH1A1 | |
| SCHEMBL5322788 | 0.79 | SMN1; SMN2 (0.53) | CYP3A4NPSR1SMN1; SMN2PKMALDH1A1 | |
| SCHEMBL18996987 | 0.79 | ALDH1A1 (0.45) | CYP3A4NPSR1SMN1; SMN2PKMALDH1A1 | |
| SCHEMBL5688510 | 0.79 | ALDH1A1 (0.47) | CYP3A4NPSR1SMN1; SMN2ALDH1A1L3MBTL1 | |
| SCHEMBL29034764 | 0.79 | CYP3A4 (0.43) | CYP3A4NPSR1SMN1; SMN2PKMALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0334633-B1 | PREPARATION OF 2,6-DIOXOPIPERIDINE DERIVATIVES | BTG INTERNATIONAL LIMITED (GB) | 1993-05-12 | — | — | EP | claimed |
| US-5112976-A | PREPARATION OF 2,6-DIOXOPIPERIDINE DERIVATIVES | NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) | 1992-05-12 | — | — | US | claimed |
| WO-1989009216-A1 | PREPARATION OF 2,6-DIOXOPIPERIDINE DERIVATIVES | NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) | 1989-10-05 | — | — | WO | claimed |
| EP-0334633-A1 | Preparation of 2,6-Dioxopiperidine derivatives | BTG INTERNATIONAL LIMITED (GB) | 1989-09-27 | — | — | EP | claimed |
| US-6677268-B2 | A METAL COMPLEXES AS HYDROFORMYLATION CATALYST OF OLEFINICALLY UNSATURATED COMPOUNDS | INSTITUT FRANCAIS DU PETROLE (FR) | 2004-01-13 | — | — | US | disclosed |
| US-20030055299-A1 | Catalyst based on cobalt and/or rhodium employed in a two-phase medium | INSTITUT FRANCAIS DU PETROLE (FR) | 2003-03-20 | — | — | US | disclosed |
| US-6469216-B2 | CO OR RH COMPLEX COORDINATED WITH A NITROGEN-CONTAINING LIGAND; QUATERNARY AMMONIUM OR PHOSPHONIUM IONIC SOLVENT | INSTITUT FRANCAIS DU PETROLE (FR) | 2002-10-22 | — | — | US | disclosed |
| EP-1157007-A1 | PDE IV INHIBITING COMPOUNDS, COMPOSITIONS AND METHODS OF TREATMENT | MERCK FROSST CANADA INC. (CA) | 2001-11-28 | — | — | EP | disclosed |
| US-20010039363-A1 | Process for hydroformylation using a catalyst based on cobalt and/or rhodium employed in a two-phase medium | INSTITUT FRANCAIS DU PETROLE (FR) | 2001-11-08 | — | — | US | disclosed |
| US-6204275-B1 | PDE IV inhibiting compounds, compositions and methods of treatment | MERCK FROSST CANADA & CO. (CA) | 2001-03-20 | — | — | US | disclosed |
| WO-2000050402-A1 | PDE IV INHIBITING COMPOUNDS, COMPOSITIONS AND METHODS OF TREATMENT | MERCK FROSST CANADA & CO. (CA) | 2000-08-31 | — | — | WO | disclosed |
| US-5661014-A | Chiral compounds and their resolution synthesis using enantioselective esterases | CHIROSCIENCE LIMITED (GB) | 1997-08-26 | — | — | US | disclosed |
| EP-0599959-A1 | CHIRAL GLUTARATE ESTERS, THEIR RESOLUTION AND DERIVED GLUTARIMIDE COMPOUNDS | Chiroscience Limited (GB) | 1994-06-08 | — | — | EP | disclosed |
| EP-0334633-B1 | PREPARATION OF 2,6-DIOXOPIPERIDINE DERIVATIVES | BTG INTERNATIONAL LIMITED (GB) | 1993-05-12 | — | — | EP | disclosed |
| WO-1993004058-A1 | CHIRAL GLUTARATE ESTERS, THEIR RESOLUTION AND DERIVED GLUTARIMIDE COMPOUNDS | CHIROSCIENCE LIMITED (GB) | 1993-03-04 | — | — | WO | disclosed |
| US-5112976-A | PREPARATION OF 2,6-DIOXOPIPERIDINE DERIVATIVES | NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) | 1992-05-12 | — | — | US | disclosed |
| WO-1989009216-A1 | PREPARATION OF 2,6-DIOXOPIPERIDINE DERIVATIVES | NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) | 1989-10-05 | — | — | WO | disclosed |
| EP-0334633-A1 | Preparation of 2,6-Dioxopiperidine derivatives | BTG INTERNATIONAL LIMITED (GB) | 1989-09-27 | — | — | EP | disclosed |